EnzeneX™: A continuous bioprocess manufacturing platform that pushes your project further
Unlocking higher yields across a range of biologics at significantly lower costs to you, our patented continuous bioprocess manufacturing platform represents the pinnacle of our ongoing commitment to innovation.
What is EnzeneX™?
EnzeneX™ is an advanced bioprocess continuous manufacturing platform that harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics.
Designed for efficiency and cost-effectiveness, EnzeneX™ enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
What can EnzeneX™ do for you?
High-quality production
EnzeneX™ minimizes product contact with cell culture fluid, ensuring high-quality manufacturing. This is crucial for biologics that are prone to degradation including less stable and difficult-to-express proteins.
Cost-effective manufacturing
EnzeneX™ reduces processing costs by approximately 40%, providing you with cost-effective manufacturing. This is achieved with a lower cost of goods and efficient use of resources.
Adaptable design
EnzeneX™ provides flexibility with a minimum 30-50L supply.
The modular and variable bioreactors enable scale-on and scale-out flexibility, allowing you to adapt to changing production needs and optimize your manufacturing capacity.
Increased productivity
EnzeneX™ increases your manufacturing productivity, achieving approximately 10 times higher productivity upstream and 25-50% improvement downstream.
Reduced emissions
EnzeneX™ increases sustainability by reducing the equipment footprint and carbon footprint of manufacturing processes.
How does EnzeneX™ work?
Discover the science behind our patented and fully validated continuous bioprocess manufacturing.
EnzeneX™ has enabled us to successfully manufacture commercial monoclonal antibodies (mAbs) and convert biologics from fed-batch production to continuous manufacturing.
Uncover the unique advantages of EnzeneX™
Patented and validated quality manufacturing
- EnzeneX™ utilizes a patented combination of intensified perfusion and multi-column chromatography, ensuring the highest quality, efficiency, and cost-effectiveness in manufacturing
- This innovative process enables consistent and reliable production of biopharmaceutical products
Primed for product scaling
- EnzeneX™ offers scalability options, allowing you to transition from small-scale production to commercial manufacturing
- Two scaling options are available:
- Scale-on: Uses the same-size bioreactors with a higher process duration
- Scale-out: Involves multiple same-size suites, providing increased capacity
Designed with flexibility in mind
- EnzeneX™ prioritizes flexibility, enabling you to adapt to the changing demands of your biologics products
- This offers lower costs when scaling up or down production and improved sustainability by reducing carbon emissions and facility footprints
Join the continuous manufacturing revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.